🇺🇸 FDA
Pipeline program

CAR-T cells

IIT2024019

Unknown other active

Quick answer

CAR-T cells for Philadelphia Positive Acute Lymphoblastic Leukemia is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Philadelphia Positive Acute Lymphoblastic Leukemia
Phase
Unknown
Modality
other
Status
active

Clinical trials